{"id":"W2753307186","doi":"10.1212/wnl.80.7_supplement.s31.006","title":"Clinical Efficacy and Safety of Peginterferon beta-1a in Relapsing Multiple Sclerosis: Data from the Pivotal Phase 3 ADVANCE Study (S31.006)","year":2013,"lang":"en","type":"article","venue":"Neurology","topic":"Hermeneutics and Narrative Identity","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Multiple sclerosis; Medicine; BETA (programming language); Phases of clinical research; Interferon beta; Clinical trial; Oncology; Internal medicine; Intensive care medicine; Immunology; Computer science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003359464,0.0007255829,0.001161057,0.0002091258,0.0003618628,0.0004831198,0.0004631002,0.0008237918,0.001913798],"category_scores_gemma":[0.001767505,0.0002054617,0.0007278718,0.0002699523,0.0005135087,0.0006038676,0.0002825336,0.001301599,0.000365556],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002738626,"about_ca_system_score_gemma":0.0005149184,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003208028,"about_ca_topic_score_gemma":0.0007171308,"domain_scores_codex":[0.9994329,0.0003549879,0.00004133293,0.00004514516,0.0000729291,0.0000527167],"domain_scores_gemma":[0.9984046,0.0004296376,0.0006199692,0.0001026203,0.000134763,0.0003085116],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7847965,0.01622957,0.02761665,0.001240625,0.002285189,0.0003333793,0.0003952827,0.001373722,0.02885365,0.0002929292,0.004059497,0.132523],"study_design_scores_gemma":[0.3958226,0.426002,0.1551185,0.000230168,0.002117532,0.001282858,0.0001922625,0.001275932,0.009091478,0.0005002393,0.008299165,0.0000673184],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991185,0.005434009,0.0002603683,0.0003132427,0.00004260013,0.0004303238,0.000699315,0.0000220826,0.00161298],"genre_scores_gemma":[0.994144,0.002203342,0.0006915371,0.0004133719,0.0001814198,0.0003134778,0.001325351,0.000009982466,0.0007175021],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003359464,"threshold_uncertainty_score":0.01776677,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1437221982439598,"score_gpt":0.33505340065776,"score_spread":0.1913312024138001,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}